Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...

Semaglutide, which is found in popular drugs Wegovy and Ozempic, is hard to replicate accurately due to its complex structure ...

GLP-1 drugs have been linked to numerous potential health benefits like treatment of existing conditions including heart ...